HGSI 13.62 -0.01 / Human Genome Sciences, Inc. News | Benzinga

Friday, May 25, 2012

Benzinga's Top Pre-Market Losers (AMD, GOLD, HGSI, News, PAY, Movers & Shakers, Pre-Market Outlook, Markets / Fri, 08:21am)

Wednesday, May 23, 2012

GlaxoSmithKline Amends HGS Tender Offer to Address Poison Pill, Requires HGS to Redeem Pill (GSK, HGSI, News, FDA, M&A / Wed, 08:37am)

Thursday, May 17, 2012

Benzinga's M&A Chatter for Thursday May 17, 2012 (A, APC, ARP, CHK, CVX, HGSI, Long Ideas, News, Short Ideas, Rumors, M&A, Global, After-Hours Center, Movers, Trading Ideas / Thu, 05:43pm)
Human Genome Looks to Anyone but GlaxoSmithKline (GSK, HGSI, News, M&A / Thu, 10:43am)
A Peek Into The Market Before The Trading Starts (ACTG, HGSI, LM, MCBI, NBY, News, Futures, Global, Pre-Market Outlook, Markets / Thu, 07:24am)
Human Genome Sciences Board of Directors Unanimously Determines GlaxoSmithKline Unsolicited Tender Offer is Inadequate and Not in the Best Interests of Stockholders (HGSI, News, M&A / Thu, 07:06am)
Human Genome Sciences Announces Adoption of Short-Term Stockholder Rights Plan (HGSI, News, M&A / Thu, 07:03am)

Thursday, May 10, 2012

GlaxoSmithKline commences tender offer to acquire Human Genome Sciences for $13 per Share (HGSI, News, M&A / Thu, 08:25am)

Wednesday, May 09, 2012

Human Genome Sciences Board of Directors to Review Unsolicited Tender Offer From GlaxoSmithKline (GSK, HGSI, News, M&A / Wed, 10:06am)
GlaxoSmithKline to Get Hostile with Offer for Human Genome (AZN, Earnings, GSK, HGSI, ILMN, News, RDEA, M&A / Wed, 09:15am)

Thursday, April 19, 2012

Benzinga's M&A Chatter for Thursday April 19, 2012 (APO, CTIC, GSK, HGSI, Long Ideas, News, WOLF, Short Ideas, Rumors, M&A, After-Hours Center, Movers, Trading Ideas / Thu, 06:03pm)
GlaxoSmithKline Bids for Human Genome Sciences (GSK, HGSI, News, FDA, M&A / Thu, 10:19am)
Benzinga's Top Pre-Market Gainers (EBAY, GILD, HGSI, MLNX, News, Pre-Market Outlook, Markets, Movers / Thu, 08:05am)
Financial Breakfast: Morning News Summary for April 19, 2012 (BAC, Bonds, CHK, CVI, DD, Earnings, EBAY, FFIV, GILD, GSK, HGSI, LUV, MS, News, PM, Futures, Guidance, Upgrades, Commodities, Downgrades, Forex, Technicals, FDA, M&A, Events, Global, Economics, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, General / Thu, 07:38am)
Human Genome Sciences Announces Rejects Offer from GlaxoSmithKline; HGS Board of Directors Authorizes Exploration of Strategic Alternatives (GSK, HGSI, News, US, USA, FDA, M&A / Thu, 06:29am)

Tuesday, April 03, 2012

From Earlier, Human Genome Sciences: GlaxoSmithKline Announces Further Data from Phase 3 Trials of Albiglutide (GSK, HGSI, News, FDA / Tue, 09:19am)
Benzinga's Top Pre-Market Gainers (HGSI, LLY, News, URBN, Pre-Market Outlook, Markets, Movers / Tue, 08:21am)

Tuesday, March 13, 2012

Benzinga's M&A Chatter for Tuesday March 13, 2012 (APO, BNHN, BRCD, DELL, DNDN, GSK, HGSI, INFN, Long Ideas, MDS, News, RAX, SI, T, TLB, WOLF, Short Ideas, Rumors, M&A, After-Hours Center, Movers, Trading Ideas / Tue, 09:26pm)

Thursday, March 08, 2012

Benzinga's M&A Chatter for Wednesday March 7, 2012 (AAPL, CHUX, COG, CSCO, ESRX, FNF, GSK, HGSI, Long Ideas, MHS, News, NUAN, RIMM, SI, TRCR, Short Ideas, Rumors, M&A, After-Hours Center, Movers, Trading Ideas / Thu, 01:15am)

Monday, February 27, 2012

Human Genome Sciences Trades Up 4% on Q4 Results (Earnings, HGSI, News, After-Hours Center, Movers / Mon, 05:41pm)

Thursday, February 23, 2012

Financial Breakfast: Morning News Summary for February 23, 2012 (Bonds, CM, DRI, Earnings, HGSI, HRL, IPXL, K, KSS, LVLT, MYL, News, OMX, PCS, Futures, Guidance, Upgrades, Commodities, Downgrades, Forex, Technicals, FDA, Events, Global, Econ #s, Economics, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, General / Thu, 08:25am)

Thursday, February 09, 2012

Benzinga's M&A Chatter for Thursday February 9, 2012 (AHGP, CAT, CMI, DE, GSK, HGSI, JRCC, Long Ideas, MTW, News, RHHBY, Short Ideas, Rumors, M&A, After-Hours Center, Movers, Trading Ideas / Thu, 06:58pm)

Wednesday, January 25, 2012

Benzinga's M&A Chatter for Wednesday January 25, 2012 (AAUKY, BHP, COCO, COG, GSK, HGSI, ILMN, Long Ideas, MRK, MT, News, RHHBY, SHLD, TXI, WLT, Short Ideas, Rumors, FDA, M&A, After-Hours Center, Movers, Tech, Trading Ideas / Wed, 09:04pm)

Friday, January 06, 2012

Benzinga's M&A Chatter for Friday January 6, 2012 (BOBE, CREE, GS, GSK, HGSI, KKR, Long Ideas, M, News, RRC, TOT, Short Ideas, Rumors, M&A, Global, After-Hours Center, Movers, Tech, Trading Ideas / Fri, 05:51pm)

Thursday, December 15, 2011

Benzinga's M&A Chatter for Thursday December 15, 2011 (AEO, ALXN, BHP, CRYP, DNDN, EK, HGSI, INCY, ITMN, KKR, Long Ideas, MNTA, News, ONXX, RIO, SGEN, SONO, SWI, VRTX, WLT, Short Ideas, Rumors, Asset Sales, M&A, After-Hours Center, Movers, Tech, Trading Ideas, General / Thu, 06:47pm)

Monday, November 07, 2011

Human Genome Sciences Completes Offering of $494.5M of Convertible Senior Notes (HGSI, News, Offerings / Mon, 01:21pm)

Friday, November 04, 2011

Human Genome Sciences Announces Multiple Abstracts Related to BENLYSTA and Systemic Lupus Erythematosus to Be Presented at the 2011 ACR/ARHP Meeting (HGSI, News, SLE, FDA, Events / Fri, 07:04am)

Thursday, November 03, 2011

Human Genome Sciences Announces Exercise of Option to Purchase Additional Notes for Total Convertible Notes Issuance of $494.5 Million (HGSI, News, Offerings / Thu, 07:02am)

Wednesday, November 02, 2011

Human Genome Sciences Prices $430 Million Convertible Notes Issuance (HGSI, News, Offerings / Wed, 11:43am)
Human Genome Sciences Announces Offering of $400M Convertible Notes (HGSI, News, Financing, Offerings / Wed, 07:24am)

Wednesday, October 26, 2011

Afternoon Movers 10/26; Technology Sector Very Volatile (DV, Earnings, FSGI, HGSI, LNG, LTBR, MEG, News, Events, After-Hours Center, Markets, Movers / Wed, 04:27pm)
End-of-Day Market Summary for October 26, 2011 (ABX, AGN, AKAM, ALB, DV, Earnings, FSGI, FSLR, GRH, HGSI, HRS, LNG, LTBR, MHS, News, PFE, VAL, Broad U.S. Equity ETFs, Upgrades, Downgrades, Contracts, Events, Global, Econ #s, Economics, After-Hours Center, Markets, Analyst Ratings, Movers, Tech, ETFs / Wed, 04:17pm)
UPDATE: Piper Jaffray Lowers PT to $15 on Human Genome Sciences (Analyst Color, Earnings, HGSI, News, Price Target, Analyst Ratings / Wed, 08:33am)

Wednesday, October 19, 2011

Human Genome Sciences Soaring on Rumors (GSK, HGSI, News, Rumors, Movers / Wed, 12:12pm)
Human Genome Sciences Spokesperson Comments on Recent Rumors (GS, GSK, HGSI, News, Rumors, General / Wed, 12:09pm)

Tuesday, October 18, 2011

Piper Jaffray Believes Timing is Right for GSK to Buy Human Genome Sciences (Analyst Color, Earnings, GSK, HGSI, News, Reiteration, M&A, Analyst Ratings / Tue, 11:22am)